‘Endocrine NAFLD’ a hormonocentric perspective of nonalcoholic fatty liver disease pathogenesis
- 1 June 2006
- journal article
- review article
- Published by Elsevier in Journal of Hepatology
- Vol. 44 (6) , 1196-1207
- https://doi.org/10.1016/j.jhep.2006.03.005
Abstract
No abstract availableKeywords
This publication has 172 references indexed in Scilit:
- Review article: the treatment of non‐alcoholic steatohepatitis with thiazolidinedionesAlimentary Pharmacology & Therapeutics, 2005
- HYPOGONADISM AND METABOLIC SYNDROME: IMPLICATIONS FOR TESTOSTERONE THERAPYJournal of Urology, 2005
- Pediatric nonalcoholic steatohepatitis associated with hypopituitarismThe Esophagus, 2005
- Treating the metabolic syndrome: telmisartan as a peroxisome proliferator-activated receptor-gamma activatorActa Diabetologica, 2005
- Is Adiponectin Involved in the Pathogenesis of Nonalcoholic Steatohepatitis?Journal of Clinical Gastroenterology, 2005
- Renin-angiotensin system inhibition prevents type 2 diabetes mellitusDiabetes & Metabolism, 2004
- Relationship of nonalcoholic hepatic steatosis to overnight low‐dose dexamethasone suppression test in obese individualsClinical Endocrinology, 2004
- The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsiesJournal of Hepatology, 2004
- Inverse association between serum adiponectin level and transaminase activities in Japanese male workersJournal of Hepatology, 2004
- Cloning of adiponectin receptors that mediate antidiabetic metabolic effectsNature, 2003